BioAssay Works LLC (BAW), a leading developer and manufacturer of lateral flow assays and reagents, is pleased to announce the appointment of Dr. Doğuş Işık and Dr. Olivier Côté as its new Chief Executive Officers. Doğuş brings extensive experience in scalable nanotechnology solutions to the role, with a proven track (more…)

BioAssay Works LLC (BAW) announces the retirement of Stephen Mefferd, BAW’s co-founder and President.   During the past 20 years at BAW, Stephen has been instrumental in leading the company from a startup to a leading developer and manufacturer of lateral flow assays and reagents. Prior to founding BAW, Stephen worked (more…)

BioAssay Works (BAW) further enhanced their assay development and manufacturing services capabilities by adding 1,000 square feet of R&D and manufacturing space. In addition, BAW acquired a new reel-to-reel membrane and gold conjugate ribbon striping machine. “The additional space and new equipment expands our manufacturing capacity significantly”, noted Vice President (more…)

Let BioAssay Works (BAW) help get your lateral flow assay to market faster. BAW specializes in developing lateral flow assays utilizing our deep expertise in gold nanoparticles. Our turnkey custom assay development and manufacturing services allow clients to quickly enter a market with a minimum investment of resources and time. (more…)